Mediation of opioid analgesia by a truncated 6-transmembrane GPCR

Journal of Clinical Investigation

Volumn 125, Issue 7, 2015, Pages 2626-2630

  Lu, Zhigang ^a   Xu, Jin ^a   Rossi, Grace C ^b   Majumdar, Susruta ^a   Pasternak, Gavril W ^a   Pan, Ying Xian ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LONG ISLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; FENTANYL; G PROTEIN COUPLED RECEPTOR; KETAZOCINE; METHADONE; MORPHINE; MU OPIATE RECEPTOR; OPIATE; PROSTAGLANDIN F2 ALPHA; IODOBENZOYLNALTREXAMIDE; NALTREXONE; NARCOTIC ANALGESIC AGENT; OPRM PROTEIN, MOUSE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ALTERNATIVE RNA SPLICING; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; EXON; LENTIVIRINAE; LENTIVIRUS INFECTION; MOUSE; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS EXPRESSION; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DEFICIENCY; GENE TARGETING; GENETICS; KNOCKOUT MOUSE; METABOLISM; PAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

ALTERNATIVE SPLICING; ANALGESICS, OPIOID; ANIMALS; EXONS; GENE TARGETING; METHADONE; MICE; MICE, KNOCKOUT; MORPHINE; NALTREXONE; PAIN; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, OPIOID, MU; RECOMBINANT PROTEINS;

EID: 84936802493     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI81070     Document Type: Article

References (19)

1. Dewire SM, et al. A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine. J Pharmacol Exp Ther. 2013;344(3):708-717.
2. Violin JD, Lefkowitz RJ. β-Arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci. 2007;28(8):416-422.
3. Grinnell SG, et al. Pharmacologic characterization in the rat of a potent analgesic lacking respiratory depression, IBNtxA. J Pharmacol Exp Ther. 2014;350(3):710-718.
4. Majumdar S, et al. Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects. Proc Natl Acad Sci U S A. 2011;108(49):19776-19783.
5. Wieskopf JS, et al. Broad-spectrum analgesic efficacy of IBNtxA is mediated by exon 11-associated splice variants of the mu-opioid receptor gene. Pain. 2014;155(10):2063-2070.
6. Majumdar S, et al. Synthesis and evaluation of aryl-naloxamide opiate analgesics targeting truncated exon 11-associated mu opioid receptor (MOR-1) splice variants. J Med Chem. 2012;55(14):6352-6362.
7. Pan Y-X, Pasternak GW. Molecular biology of mu opioid receptors. In: Pasternak GW, ed. The Opiate Receptors. 2nd ed. New York, New York, USA: Springer; 2011:121-160.
8. Pasternak GW, Pan Y-X. Mu opioids and their receptors: Evolution of a concept. Pharmacol Rev. 2013;65(4):1257-1317.
9. Schuller AG, et al. Retention of heroin and morphine-6 β-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat Neurosci. 1999;2(2):151-156.
10. Pan YX, Xu J, Xu M, Rossi GC, Matulonis JE, Pasternak GW. Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions. Proc Natl Acad Sci U S A. 2009;106(12):4917-4922.
11. Wise H. The roles played by highly truncated splice variants of G protein-coupled receptors. J Mol Signal. 2012;7(1):13.
12. Tian M, et al. Altered hematopoiesis, behavior, and sexual function in μ opioid receptor-deficient mice. J Exp Med. 1997;185(8):1517-1522.
13. Sora I, et al. Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci U S A. 1997;94(4):1544-1549.
14. Loh HH, Liu HC, Cavalli A, Yang WL, Chen YF, Wei LN. μ Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Mol Brain Res. 1998; 54(2):321-326.
15. Matthes HW, et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature. 1996;383(6603):819-823.
16. Xu J, et al. Stabilization of morphine tolerance with long-term dosing: Association with selective upregulation of mu-opioid receptor splice variant mRNAs. Proc Natl Acad Sci U S A. 2014;112(1):279-284.
17. Xu J, et al. Stabilization of the mu opioid receptor by truncated single transmembrane splice variants through a chaperone-like action. J Biol Chem. 2013;288(29):21211-21227.
18. Hylden JL, Wilcox GL. Intrathecal morphine in mice: A new technique. Eur J Pharmacol. 1980;67(2-3):313-316.
19. Rossi GC, Pan Y-X, Brown GP, Pasternak GW. Antisense mapping the MOR-1 opioid receptor: Evidence for alternative splicing and a novel morphine-6β-glucuronide receptor. FEBS Lett. 1995;369(2-3):192-196.